‘We’re Not Going to Be Bullied’: Sentara Digs in on Anthem Contract Fight
Sentara Health notified Anthem that it will let its commercial, Medicare and Medicaid contracts expire at year's end unless the two sides reach a new rate agreement. The dispute puts coverage for an estimated 380,000 Virginians at risk.
Apnimed’s IPO Bags $192M for What Could Become the First Oral Sleep Apnea Drug
Apnimed will apply the IPO proceeds toward the regulatory process and launch plans of Oxnimbi, a once-nightly pill developed for obstructive sleep apnea. This drug is under FDA review with a February 2027 target date for a regulatory decision.
4 Notable Health Tech Funding Announcements in July
Health tech companies made several major funding announcements in July. Here is a list of some of the biggest funding rounds.
The Next Phase of Value-Based Care: Why Specialty-Led Models Will Define the Future of Healthcare
The future of value-based care will hinge on empowering providers, and specialists in particular, with the data and strategic partnerships to proactively manage patient health beyond traditional clinical settings.
Hope Is Not a Soft Concept, It’s a Strategic Imperative in Cancer Innovation
Hope is a catalyst for scientific ambition. It encourages researchers, clinicians, investors, and innovators to pursue solutions where none currently exist. In oncology, many major breakthroughs begin with the belief that a better answer is possible.